EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

68 Ga-PSMA PET/CT–Based Atlas for Prostate Bed Recurrence After Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines

Ida Sonni, Alan Dal Pra, Dylan P O'Connell, Zachary Ells, Matthias Benz, Kathleen Nguyen, Stephanie M Yoon, Jie Deng, Clayton Smith, Tristan Grogan, Nickolas G Nickols, Minsong Cao und 2 weitere

Journal of Nuclear Medicine · 2023

DOI: 10.2967/jnumed.122.265025 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Nuclear Medicine, 2023. Verfasst von Ida Sonni und 13 weiteren Autor:innen. Beteiligte Einrichtung: Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of Califo…. Hauptthemen laut MEDLINE: Prostate, Prostatic Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to analyze the patterns of prostate bed (PB) recurrence in prostate cancer patients experiencing prostate-specific antigen (PSA) persistence (BCP) or biochemical recurrence (BCR) after radical prostatectomy using 68Ga-PSMA-11 PET/CT (68Ga-PSMA PET) in relation to the Radiation Therapy Oncology Group (RTOG) clinical target volumes (CTVs).

Methods

This single-center, retrospective analysis included patients with BCP or BCR after radical prostatectomy and PB recurrence on 68Ga-PSMA PET. The PB recurrences were delineated by nuclear medicine physicians, the CTVs by radiation oncologists contouring guidelines on the 68Ga-PSMA PET, respectively, masked from each other. The coverage of the 68Ga-PSMA PET recurrence was categorized as PSMA recurrence completely covered, partially covered, or not covered by the RTOG-based CTV. Further, we evaluated the differences in PSMA recurrence patterns among patients with different 68Ga-PSMA PET staging (miTNM). Mann-Whitney U tests, the chi-square test, and Spearman (ρ) correlation analysis were used to investigate associations between CTV coverage and 68Ga-PSMA PET-based tumor volume, serum PSA levels, miTNM, and rectal/bladder involvement.

Results

A total of 226 patients were included in the analysis; 127 patients had PSMA recurrence limited to the PB (miTrN0M0), 30 had pelvic nodal disease (miTrN1M0), 32 had extrapelvic disease (miTrN0M1), and 37 had both pelvic nodal disease and extrapelvic disease (miTrN1M1). In the miTrN0M0 cohort, the recurrence involved the rectal and bladder walls in 12 of 127 (9%) and 4 of 127 (3%), respectively. The PSMA-positive PB recurrences were completely covered by the CTV in 68 of 127 patients (53%), partially covered in 43 of 127 (34%), and not covered in 16 of 127 (13%). Full coverage was associated with a smaller tumor volume (P = 0.043), a lack of rectal/bladder wall involvement (P = 0.03), and lower miTNM staging (P = 0.035) but not with lower serum PSA levels (P = 0.979).

Conclusion

Our study suggests that 68Ga-PSMA PET can be a valuable tool for guiding salvage radiation therapy (SRT) planning directed to the PB in the setting of postoperative BCR or BCP. These data should be incorporated into the redefinition of PB contouring guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstateProstatic NeoplasmsMaleHumansProstate-Specific AntigenPositron Emission Tomography Computed TomographyRetrospective StudiesGallium RadioisotopesProstatectomySalvage TherapyNeoplasm Recurrence, LocalGallium Isotopes

Stichwörter der Autor:innen

68Ga-PSMA PETRTOGprostate bed recurrenceprostate cancersalvage radiation

Substanzen

Prostate-Specific AntigenGallium Radioisotopesgallium 68 PSMA-11Gallium Isotopes

Autor:innen und Institutionen

  • Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California; isonni@mednet.ucla.edu.
  • Department of Radiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Nuclear Medicine Unit, Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy.
  • Department of Radiation Oncology, Miller School of Medicine, University of Miami, Miami, Florida.
  • Department of Radiation Oncology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

Förderung

  • NCI NIH HHS

Zitieren

APA

Sonni, I., Dal Pra, A., O'Connell, D. P., Ells, Z., Benz, M., Nguyen, K., Yoon, S. M., Deng, J., Smith, C., Grogan, T., Nickols, N. G., Cao, M., Kishan, A. U., & Calais, J. (2023). 68 Ga-PSMA PET/CT–Based Atlas for Prostate Bed Recurrence After Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.122.265025

Vancouver

Sonni I, Dal Pra A, O'Connell DP, Ells Z, Benz M, Nguyen K, et al. 68 Ga-PSMA PET/CT–Based Atlas for Prostate Bed Recurrence After Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines. Journal of Nuclear Medicine. 2023. doi:10.2967/jnumed.122.265025

BibTeX
@article{Sonni2023,
  author = {Sonni, Ida and Dal Pra, Alan and O'Connell, Dylan P and Ells, Zachary and Benz, Matthias and Nguyen, Kathleen and Yoon, Stephanie M and Deng, Jie and Smith, Clayton and Grogan, Tristan and Nickols, Nickolas G and Cao, Minsong and Kishan, Amar U and Calais, Jeremie},
  title = {68 Ga-PSMA PET/CT–Based Atlas for Prostate Bed Recurrence After Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines},
  journal = {Journal of Nuclear Medicine},
  year = {2023},
  doi = {10.2967/jnumed.122.265025}
}
Kostenlos starten →